<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28646892</article-id><article-id pub-id-type="pmc">5482967</article-id><article-id pub-id-type="publisher-id">2013</article-id><article-id pub-id-type="doi">10.1186/s13063-017-2013-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Effect of acupuncture on cerebrovascular reserve in patients with acute cerebral infarction: protocol for a randomized controlled pilot study</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Shaosong</given-names></name><address><phone>86-10-13269211249</phone><email>wangssmail@163.com</email><email>wangss@163.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ma</surname><given-names>Tingting</given-names></name><address><phone>86-10-15010703259</phone><email>tingtingntyy@163.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Linpeng</given-names></name><address><phone>+86 010 52176644</phone><phone>86-10-13911406703</phone><email>wlp5558@sina.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Lu</given-names></name><address><email>lululalavictor1985@126.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Huilin</given-names></name><address><email>hlxwy@126.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Bin</given-names></name><address><email>libin0314@sina.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Yuanbo</given-names></name><address><email>fybsir@126.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.459365.8</institution-id><institution>Acupuncture and Moxibustion Department, </institution><institution>Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, </institution></institution-wrap>Backstreet Gallery No. 23, Dongcheng District, Beijing, China </aff></contrib-group><pub-date pub-type="epub"><day>24</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>18</volume><elocation-id>292</elocation-id><history><date date-type="received"><day>22</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>23</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">The incidence of cerebral infarction has been growing year by year in China and around the world. According to clinical observation, acupuncture utilizing the &#x0201c;waking up the spirit&#x0201d; needling method is widely used in patients with cerebral infarction, though the underlying mechanisms remain unclear. Additionally, a number of studies have begun to focus on the relationship between cerebrovascular reserve (CVR) and cerebral infarction. The present study aims to investigate whether CVR is one of potential mechanisms underpinning this effect of acupuncture on patients with cerebral infarction.</p></sec><sec><title>Methods</title><p id="Par2">This is a single-centre, prospective, single-blinded, randomized controlled pilot study. Sixty eligible patients will be randomized into an intervention group (waking up the spirit acupuncture) and a control group (hand and foot 12-meridian acupuncture) in a 1:1 ratio. All treatments will be conducted once a day on weekdays followed by a 2-day rest period on the weekend, over a total treatment course of 2&#x000a0;weeks. The primary outcome measures are cerebrovascular reserve (CVR) capacity and Breath-holding Index (BHI) which will be evaluated at baseline and 2&#x000a0;weeks after the first acupuncture treatment, and the secondary outcome measures are National Institutes of Health Stroke Scale (NIHSS) and Barthel Index scores which will be used to further evaluate the efficacy of the intervention.</p></sec><sec><title>Discussion</title><p id="Par3">Cerebrovascular reserve is an independent risk factor for the occurrence, progression, and recurrence of cerebral infarction that requires attention. This trial aims to investigate whether acupuncture utilizing the waking up the spirit needling method can improve CVR capacity in patients with acute cerebral infarction, thus reducing NIHSS scores and preventing further progression of the disease. Furthermore, data and evidence gained from this study will be utilized in the development of future research projects regarding the effects of acupuncture in patients with acute cerebral infarction.</p></sec><sec><title>Trial registration</title><p id="Par4">ISRCTN, ID: <ext-link ext-link-type="uri" xlink:href="http://www.isrctn.com/ISRCTN99117074">ISRCTN99117074</ext-link>. Registered on 20 April 2016.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s13063-017-2013-5) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Stroke</kwd><kwd>Cerebrovascular reserve</kwd><kwd>Acupuncture</kwd><kwd>Acute cerebral infarction</kwd><kwd>Acupoints</kwd></kwd-group><funding-group><award-group><funding-source><institution>Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support</institution></funding-source><award-id>ZYLX201412</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Linpeng</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution>Beijing Traditional Chinese Medicine Science and Technology Project</institution></funding-source><award-id>JJ2014-10</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Shaosong</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution>Beijing Natural Science Foundation</institution></funding-source><award-id>7154206</award-id><principal-award-recipient><name><surname>Fu</surname><given-names>Yuanbo</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p id="Par19">Acute cerebral infarction is a relatively common condition whose incidence is increasing around the world, with high rates of morbidity, mortality, and disability [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>]. Increasingly stressful social conditions and unhealthy lifestyles contribute to the increased incidence of cerebral infarction in younger individuals [<xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR10">10</xref>], negatively impacting both families and society at large [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. The incidence of cerebral infarction in China is nearly the highest in the world, and cerebrovascular disease has ranked among the leading causes of death in China since 2008 [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>] and has become the third leading cause of death, behind malignant neoplasms and heart disease, according to a 2014 fact sheet published by the Chinese CDC [<xref ref-type="bibr" rid="CR14">14</xref>]. Systematic analyses have estimated that about 1.7 billion Chinese patients die of cerebral infarction every year, with a recurrence rate greater than 17.1% [<xref ref-type="bibr" rid="CR11">11</xref>] in surviving individuals.</p><p id="Par20">Cerebral infarction is closely related to cerebrovascular stenosis or cerebral thrombosis. Deficiencies in cerebral perfusion are associated with three compensatory mechanisms of the cerebrovasculature: establishment of collateral circulation, cerebrovascular reserve (CVR), and metabolic reserve. CVR&#x02014;also known as cerebral blood flow reserve, cerebral perfusion reserve, and cerebral circulation reserve&#x02014;refers to the ability of the cerebrovasculature to maintain normal cerebral blood flow under physiological or pathological stimulation by via compensatory adjustment of small arteries and capillaries [<xref ref-type="bibr" rid="CR15">15</xref>]. In the early stages of cerebral ischemia, collateral circulation is established, and blood flow velocity is increased in order to maintain cerebral perfusion volume. When the collateral circulation can no longer compensate for the deficiency in perfusion, CVR begins to increase perfusion by dilating small cerebral arteries and capillaries. When CVR can no longer support further increases in cerebral perfusion volume, brain tissue can only maintain the intracranial blood supply by increasing oxygen fraction extraction. However, as the degree of cerebral anoxia worsens, acute infarction becomes more likely to occur [<xref ref-type="bibr" rid="CR16">16</xref>]. Patients with low CVR tend to experience more severe hypoperfusion, ischemia, and hypoxia, leading to infarction and further tissue damage [<xref ref-type="bibr" rid="CR17">17</xref>]. Deficient CVR is not only an independent risk factor for cerebral infarction [<xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR21">21</xref>] but also a risk factor for the progression [<xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>] and recurrence [<xref ref-type="bibr" rid="CR26">26</xref>] of cerebral infarction. Therefore, the development of novel strategies for increasing CVR in patients with acute infarction is crucial for preventing the progression and recurrence of infarction.</p><p id="Par21">The treatment of acute ischemic cerebral infarction aims to maintain the blood supply and oxygenation of the ischemic penumbra. CVR is closely connected with cerebrovascular diseases and research on cerebrovascular disease has become increasingly focused on CVR [<xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR32">32</xref>]. Research has also indicated that acupuncture exerts specific effects on blood flow velocity, vascular reactivity, and circulation [<xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>], suggesting that acupuncture may improve outcomes in patients with diminished CVR. To the best of our knowledge, however, reports have yet to demonstrate the effect of acupuncture on CVR. Therefore, the present study aims to investigate whether acupuncture utilizing [<xref ref-type="bibr" rid="CR37">37</xref>] the &#x0201c;waking up the spirit&#x0201d; needling method can improve CVR capacity in patients with acute cerebral infarction. Different methods of acupuncture have varying influences on blood flow, and stronger stimulation may be required to improve blood flow in patients with cerebral infarction [<xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR41">41</xref>]. Acupuncture utilizing the waking up the spirit needling method provides intense stimulation of the head and limbs by means of bloodletting at certain acupoints, and the positive effects of acupuncture in general have been documented with regard to a number of conditions, including increased cerebral blood flow in the region surrounding the ischemic area [<xref ref-type="bibr" rid="CR42">42</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref>]. Butylphthalide [<xref ref-type="bibr" rid="CR45">45</xref>] has an effect on patients with acute cerebral infarction; the underlying mechanism maybe that it changes CVR by changing blood flow. As with butylphthalide, we are trying to explore whether acupuncture, utilizing the waking up the spirit needling method, has the same routine mechanism that can improve CVR in patients with acute cerebral infarction, thus reducing scores on the National Institutes of Health Stroke Scale (NIHSS) and preventing further disease progression.</p><p id="Par22">Though a variety of methods may be used to assess CVR (positron emission tomography (PET), single photon emission computed tomography, computed tomography (CT) angiography, magnetic resonance (MR) angiography, transcranial Doppler (TCD) sonography, etc. [<xref ref-type="bibr" rid="CR46">46</xref>], PET is the most effective in evaluating the capacity for vascular dilatation. However, this method is expensive and relatively underutilized in China. TCD, on the other hand, allows for the noninvasive examination of local blood flow velocity in the middle cerebral artery [<xref ref-type="bibr" rid="CR47">47</xref>]. Blood flow is proportional to blood flow velocity [<xref ref-type="bibr" rid="CR48">48</xref>], allowing for the indirect evaluation of CVR using TCD. TCD has been utilized in clinical examination for nearly 30&#x000a0;years and is easy to perform, noninvasive, inexpensive, and repeatable [<xref ref-type="bibr" rid="CR47">47</xref>]. Some studies have also reported that TCD is effective in evaluating cerebrovascular reactivity using the breath-holding test. [<xref ref-type="bibr" rid="CR49">49</xref>&#x02013;<xref ref-type="bibr" rid="CR51">51</xref>]. For these reasons, we chose TCD to assess CVR in the present study.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Methods</title><sec id="Sec3"><title>Objectives</title><p id="Par23">The present study aims to test the hypothesis that acupuncture utilizing the waking up the spirit needling method can improve CVR capacity in patients with acute cerebral infarction, thus reducing NIHSS scores and preventing further disease progression.</p></sec><sec id="Sec4"><title>Recruitment</title><p id="Par24">The present study is a single-center, prospective single-blinded, randomized controlled pilot trial to be carried out in three stages (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>): a recruitment period prior to baseline assessment and randomization, a treatment and observation period of 2&#x000a0;weeks, and a final follow-up period. All participants will be recruited from the three acupuncture wards of Beijing Hospital of Traditional Chinese Medicine at Capital Medical University (Beijing, China). In the first stage, we will seek out potentially qualified patients according to the inclusion and exclusion criteria and provide them with detailed information about the study such as the research objective, study procedure, and both the potential benefits and risks. If a patient agrees to participate, they will be asked to voluntarily provide written informed consent, following which baseline assessments and randomization will be conducted. Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> depicts the timetable of the trial. Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> illustrates the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure which the trial protocol follows (Additional file <xref rid="MOESM1" ref-type="media">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Flow chart</p></caption><graphic xlink:href="13063_2017_2013_Fig1_HTML" id="MO1"/></fig>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Time table</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th rowspan="2">Baseline (before treatment)</th><th colspan="3">Treatment</th><th>Follow-up and data collection</th></tr><tr><th>Week 0</th><th>Week 1</th><th>Week 2</th><th>Data collection and analysis</th></tr></thead><tbody><tr><td colspan="6">Patients entered</td></tr><tr><td>&#x02003;Medical history</td><td>&#x0221a;</td><td/><td/><td/><td/></tr><tr><td>&#x02003;GCS</td><td>&#x0221a;</td><td/><td/><td/><td/></tr><tr><td>&#x02003;CVR</td><td>&#x0221a;</td><td/><td/><td/><td/></tr><tr><td>&#x02003;Sign the informed consent</td><td>&#x0221a;</td><td/><td/><td/><td/></tr><tr><td>&#x02003;Randomization</td><td>&#x0221a;</td><td/><td/><td/><td/></tr><tr><td>&#x02003;Intervention</td><td/><td>&#x0221a;</td><td>&#x0221a;</td><td>&#x0221a;</td><td/></tr><tr><td>Outcomes</td><td/><td/><td/><td/><td/></tr><tr><td>Primary outcomes</td><td/><td/><td/><td/><td/></tr><tr><td>&#x02003;CVR</td><td/><td>&#x0221a;</td><td/><td>&#x0221a;</td><td/></tr><tr><td>&#x02003;BHI</td><td/><td>&#x0221a;</td><td/><td>&#x0221a;</td><td/></tr><tr><td>Secondary outcome</td><td/><td/><td/><td/><td/></tr><tr><td>&#x02003;NIHSS</td><td/><td>&#x0221a;</td><td>&#x0221a;</td><td>&#x0221a;</td><td/></tr><tr><td>&#x02003;Barthel Index</td><td/><td>&#x0221a;</td><td>&#x0221a;</td><td>&#x0221a;</td><td/></tr><tr><td>Adverse events</td><td>&#x0221a;</td><td>&#x0221a;</td><td>&#x0221a;</td><td>&#x0221a;</td><td>&#x0221a;</td></tr><tr><td>Data collection</td><td/><td/><td/><td/><td>&#x0221a;</td></tr></tbody></table><table-wrap-foot><p>
<italic>GCS</italic> Glasgow Coma Scale, <italic>CVR</italic> cerebrovascular reserve, <italic>BHI</italic> Breath-holding Index, <italic>NIHSS</italic> National Institutes of Health Stroke Scale</p></table-wrap-foot></table-wrap>
<fig id="Fig2"><label>Fig. 2</label><caption><p>Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure</p></caption><graphic xlink:href="13063_2017_2013_Fig2_HTML" id="MO2"/></fig>
</p></sec><sec id="Sec5"><title>Design</title><sec id="Sec6"><title>Randomization and allocation concealment</title><p id="Par25">The randomization scheme was provided by a random number table. A set of 60 random numbers was generated by a designated computer, and each number was then divided by 2. Resulting numbers with a remainder of 0 corresponded to the treatment group, while those with a remainder of 1 corresponded to the control group. However, this system resulted in 36 control numbers and only 24 treatment numbers, so it was necessary to re-assign six numbers from the control group to the treatment group. The next six numbers were chosen from the random number table and divided by 36, resulting in the following remainders: 26, 24, 6, 2, 22, and 14. Therefore, we assigned patient numbers 26, 24, 6, 2, 22, and 14 into the treatment group, resulting in a total of 30 patients in each group. Participants will be allocated into one of these two groups according to the order in which they are recruited.</p></sec><sec id="Sec7"><title>Blinding</title><p id="Par26">The therapists will be aware of the treatments in both groups as they are experienced enough to distinguish between the treatment methods; however, the participants will remain blinded to the treatment. Participants will be told that they have been randomly allocated to either the treatment group or the control group, and they will be treated with bloodletting using a three-edged needle, regular acupuncture, or both, based upon their condition. Moreover, the study will utilize independent data managers and statisticians who will also remained blinded to the intervention methods throughout the trial. All therapists, data managers, and statisticians have been requested to refrain from communication with each other regarding the study.</p></sec></sec><sec id="Sec8"><title>Participants</title><sec id="Sec9"><title>Sample size</title><p id="Par27">As we were unable to find any publication regarding acupuncture for CVR capacity, we could not calculate the appropriate sample size according to the sample size calculation formula. We determined an appropriate sample size of 60 for a pilot study. Both the treatment and control groups will contain 30 eligible participants. The outcomes of this study will aid in the calculation of the appropriate sample size for further randomized clinical trials.</p></sec><sec id="Sec10"><title>Inclusion criteria</title><p id="Par28">Patients of either sex are eligible for entry into this study if they meet the following inclusion criteria: (1) age between 30 and 80&#x000a0;years with acute cerebral infarction, with an onset time of less than 7&#x000a0;days, (2) confirmed as meeting the Western medicine diagnostic criteria for cerebral infarction issued by the American Heart Association/American Stroke Association (AHA/ASA) in 2015 [<xref ref-type="bibr" rid="CR52">52</xref>], (3) confirmed as meeting the traditional Chinese medicine diagnostic criteria developed by the Stroke Diagnosis and Curative Effect Evaluation Standard (Draft) of the State Administration of Traditional Chinese Medicine, Acute Encephalopathy Research Group [<xref ref-type="bibr" rid="CR53">53</xref>], (4) confirmation of diagnosis by head CT or MRI, (5) confirmed CVR impairment as assessed using the breath-holding-test, (6) NIHSS score within the range of 5&#x02013;20 points, (7) Glasgow Coma Scale score &#x02265;12 points, and (8) agreement to participate in this trial and signing an signed Informed Consent Form.</p></sec><sec id="Sec11"><title>Exclusion criteria</title><p id="Par29">Patients are ineligible if they meet the following exclusion criteria: (1) use of antithrombotics such as low molecular heparin for the treatment of another conditions, (2) carotid artery stent in situ, (3) severe heart, lung, or kidney disease, (4) inability to cooperate during ultrasound examination of the brain or quantitative evaluation due to another condition.</p></sec><sec id="Sec12"><title>Discontinuation criteria</title><p id="Par30">Reasons for discontinuation of treatment may include, but are not limited to, the following: (1) participant&#x02019;s decision to discontinue treatment at any time for any reason, (2) investigator&#x02019;s determination to discontinue treatment for the patient&#x02019;s safety and best interests at any time, (3) inability to tolerate the treatment stimulation at any time during the course of the study, (4) occurrence of serious side effects during the treatment course, (5) exacerbation of the disease making it difficult for the participant to continue treatment, (6) inability of the participant to cooperate during assessment for any reason, and (7) concomitant therapy during the trial that may affect the study results.</p></sec><sec id="Sec13"><title>Loss to follow-up</title><p id="Par31">An intention-to-treat approach will be used, and reasons for which patients have been lost to follow-up must be recorded in detail and analyzed after the trial. If the number of cases lost to follow-up is within 10% of all participants, the data from these cases will not be included in the analysis. If the number of cases lost to follow-up exceeds 10%, data from the cases lost in the treatment group will be regarded as invalid, while data from the cases lost in the control group will be regarded as valid. Thus, the effective percentage of the treatment group will remain higher than that of the control group, allowing us to further analyze the efficacy of the intervention.</p></sec></sec><sec id="Sec14"><title>Intervention</title><p id="Par32">A bloodletting regimen, using a three-edged needle, will be performed based upon descriptions in the ancient literature and our clinical experience. The bloodletting will be performed by certified acupuncturists with at least 20&#x000a0;years of clinical experience. All treatment details will be standardized among practitioners who will receive relevant training and video guidance prior to the first acupuncture session. Patients will adopt a supine position during the treatment. The operators will sterilize the skin of an area of 3&#x000a0;cm around the acupoints with 75% alcohol. Participants in the treatment group will receive acupuncture utilizing the waking up the spirit needling method, while participants in the control group will be treated using 12-meridian hand and foot acupuncture. All treatments will be performed once a day on weekdays, followed by a 2-day rest period on weekends, for a total course of 2&#x000a0;weeks. Each treatment session will last approximately 35&#x000a0;min: the first 5&#x000a0;min will consist of the acupuncture procedure, following which the needles will be retained for 30&#x000a0;min in the patients of both the treatment and control groups.</p><sec id="Sec15"><title>Treatment group</title><p id="Par33">Acupuncture utilizing the waking up the spirit needling method will be performed as follows. First, patients will adopt a supine position, then the operators will sterilize the skin of an area of 3&#x000a0;cm around acupoints with 75% alcohol. Acupuncture bloodletting will be conducted at acupoints <italic>Bai Hui</italic> (DU-20), <italic>Si Shen Cong</italic> (EX-HN1), and at 12 well-points using a three-edged needle which will be inserted into the skin at a depth of approximately 5&#x02013;10&#x000a0;mm. The needle will be withdrawn immediately, and the skin around the pin hole will be squeezed to release a few drops of blood. The 12 well-points are <italic>Shao Shang</italic> (LU-11), <italic>Shang Yang</italic> (LI-1), <italic>Li Dui</italic> (ST-45), <italic>Yin Bai</italic> (SP-1), <italic>Shao Chong</italic> (HT-9), <italic>Shao Ze</italic> (SI-1), <italic>Zhi Yin</italic> (BL-67), <italic>Yong Quan</italic> (KI-1), <italic>Zhong Chong</italic> (PC-9), <italic>Guan Chong</italic> (SJ-1), <italic>Zu Qiao Yin</italic> (GB-44), and <italic>Da Dun</italic> (LR-1). Lastly, other points, such as <italic>Ren Zhong</italic> (GV-26), <italic>Cheng Jiang</italic> (CV-24), <italic>Feng Chi</italic> (GB-20), <italic>He Gu</italic> (LI-4), <italic>Lao Gong</italic> (PC-8), <italic>Tai Chong</italic> (LV-3), and <italic>Yong Quan</italic> (K-I1), will be chosen after the bloodletting, and the filiform needles will be inserted to depth of 10&#x02013;15&#x000a0;mm and manually manipulated by rotation in order to produce a characteristic sensation known as &#x0201c;<italic>De Qi</italic>.&#x0201d; Techniques of mild reinforcing and attenuating will be applied, and the filiform needles will be retained for 30&#x000a0;min.</p></sec><sec id="Sec16"><title>Control group</title><p id="Par34">Twelve-meridian hand and foot acupuncture will be performed as follows. First, patients will be asked to adopt the supine position, and the operators will sterilize a 3-cm skin area around acupoints with 75% alcohol. Acupuncture including the <italic>Qu Chi</italic> (LI-11), <italic>Nei Guan</italic> (PC-6), <italic>He Gu</italic> (LI-4), <italic>Yang Ling Quan</italic> (GB-34), <italic>Zu San Li</italic> (ST-36), and <italic>San Yin Jiao</italic> (SP-6) points will be stimulated with filiform needles to a depth of 10&#x02013;15&#x000a0;mm. The needles will be manually manipulated by rotation methods in order to produce a characteristic sensation known as <italic>De Qi</italic>. Techniques of mild reinforcing and attenuating will be applied, and the filiform needles will be retained for 30&#x000a0;min.</p></sec><sec id="Sec17"><title>Follow-up</title><p id="Par35">All participants will continue to undergo conventional therapy according to the National Clinical Guideline for Stroke [<xref ref-type="bibr" rid="CR54">54</xref>]. Recurrence rate and Barthel Index scores will be assessed at the 3- and 6-month follow-ups for further information related to prognosis, though these will not be factored in to our assessment of the main outcomes.</p></sec></sec><sec id="Sec18"><title>Outcome measures</title><sec id="Sec19"><title>Primary outcome measures: CVR and BHI</title><p id="Par36">
<list list-type="order"><list-item><p id="Par37">Cerebrovascular reserve (CVR)</p><p id="Par38">CVR will be calculated at baseline and 2&#x000a0;weeks after the first acupuncture session according to the following formula, in which the mean blood flow velocity (MFV) of the bilateral middle cerebral artery is measured using the transcranial Doppler (TCD) Breath-holding Test:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{l} CVR = \left( MFV\ \mathrm{after}\ \mathrm{breath}\hbox{-} \mathrm{holding}\ \hbox{--}\ MFV\ \mathrm{before}\ \mathrm{breath}\hbox{-} \mathrm{holding}\right)/ MFV\ \mathrm{before}\\ {}\ \mathrm{breath}\hbox{-} \mathrm{holding} \times 100\%.\end{array} $$\end{document}</tex-math><mml:math id="M2"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi mathvariant="italic">C</mml:mi><mml:mi mathvariant="italic">V</mml:mi><mml:mi mathvariant="italic">R</mml:mi><mml:mspace width="0.25em"/><mml:mo>=</mml:mo><mml:mspace width="0.25em"/><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="italic">M</mml:mi><mml:mi mathvariant="italic">F</mml:mi><mml:mi mathvariant="italic">V</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">after</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">breath</mml:mi><mml:mo>&#x02010;</mml:mo><mml:mi mathvariant="normal">holding</mml:mi><mml:mspace width="0.25em"/><mml:mo>&#x02013;</mml:mo><mml:mspace width="0.25em"/><mml:mi mathvariant="italic">M</mml:mi><mml:mi mathvariant="italic">F</mml:mi><mml:mi mathvariant="italic">V</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">before</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">breath</mml:mi><mml:mo>&#x02010;</mml:mo><mml:mi mathvariant="normal">holding</mml:mi></mml:mrow></mml:mfenced><mml:mo stretchy="true">/</mml:mo><mml:mi mathvariant="italic">M</mml:mi><mml:mi mathvariant="italic">F</mml:mi><mml:mi mathvariant="italic">V</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">before</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">breath</mml:mi><mml:mo>&#x02010;</mml:mo><mml:mi mathvariant="normal">holding</mml:mi><mml:mspace width="0.25em"/><mml:mo>&#x000d7;</mml:mo><mml:mspace width="0.25em"/><mml:mn>100</mml:mn><mml:mo>%</mml:mo><mml:mtext>.</mml:mtext></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="13063_2017_2013_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>
</p><p id="Par39">CVR function is considered impaired if the calculated CVR is less than 20%.</p><p id="Par40">CVR will be accessed via the TCD breath-holding test. For this test, patients are instructed to practice holding their breath at least twice prior to assessment. Patients then adopt the supine position and are asked to breathe normally for 5&#x000a0;min. Two ultrasonic probes are then placed on the bilateral temporal window and connected to the EMS-9&#x000a0;W TCD machine (Nanjing Bangao Company, Nanjing, China). The ultrasonic probe is used to record at a depth of roughly 50&#x02013;55&#x000a0;mm, measuring blood velocity in the bilateral middle cerebral artery (M1). Once an adequate signal has been obtained, the probes are fixed, and the MFV is recorded while the patient is in a calm state. The patient is then asked to hold their breath for at least 15&#x000a0;s, following which the MFV is re-recorded.</p></list-item><list-item><p id="Par41">Breath-holding Index (BHI)</p><p id="Par42">BHI assessments will be conducted at baseline and 2&#x000a0;weeks after the first acupuncture session according to the following formula, in which the MFV of the bilateral middle cerebral artery is measured using the TCD breath-holding test:<disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{l} BHI = \left( MFV\ \mathrm{after}\ \mathrm{breath}\hbox{-} \mathrm{holding}\ \hbox{--}\ MFV\ \mathrm{before}\ \mathrm{breath}\hbox{-} \mathrm{holding}\right)/ MFV\ \mathrm{before}\ \\ {}\mathrm{breath}\hbox{-} \mathrm{holding} \times \left(100/\mathrm{time}\ \mathrm{holding}\ \mathrm{breath}\right).\end{array} $$\end{document}</tex-math><mml:math id="M4"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi mathvariant="italic">B</mml:mi><mml:mi mathvariant="italic">H</mml:mi><mml:mi mathvariant="italic">I</mml:mi><mml:mspace width="0.25em"/><mml:mo>=</mml:mo><mml:mspace width="0.25em"/><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="italic">M</mml:mi><mml:mi mathvariant="italic">F</mml:mi><mml:mi mathvariant="italic">V</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">after</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">breath</mml:mi><mml:mo>&#x02010;</mml:mo><mml:mi mathvariant="normal">holding</mml:mi><mml:mspace width="0.25em"/><mml:mo>&#x02013;</mml:mo><mml:mspace width="0.25em"/><mml:mi mathvariant="italic">M</mml:mi><mml:mi mathvariant="italic">F</mml:mi><mml:mi mathvariant="italic">V</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">before</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">breath</mml:mi><mml:mo>&#x02010;</mml:mo><mml:mi mathvariant="normal">holding</mml:mi></mml:mrow></mml:mfenced><mml:mo stretchy="true">/</mml:mo><mml:mi mathvariant="italic">M</mml:mi><mml:mi mathvariant="italic">F</mml:mi><mml:mi mathvariant="italic">V</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">before</mml:mi><mml:mspace width="0.25em"/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi mathvariant="normal">breath</mml:mi><mml:mo>&#x02010;</mml:mo><mml:mi mathvariant="normal">holding</mml:mi><mml:mspace width="0.25em"/><mml:mo>&#x000d7;</mml:mo><mml:mspace width="0.25em"/><mml:mfenced close=")" open="("><mml:mrow><mml:mn>100</mml:mn><mml:mo stretchy="true">/</mml:mo><mml:mi mathvariant="normal">time</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">holding</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">breath</mml:mi></mml:mrow></mml:mfenced><mml:mtext>.</mml:mtext></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="13063_2017_2013_Article_Equb.gif" position="anchor"/></alternatives></disp-formula>
</p></list-item></list>
</p></sec><sec id="Sec20"><title>Secondary outcome measures: NIHSS and Barthel Index scores</title><p id="Par43">
<list list-type="order"><list-item><p id="Par44">NIHSS [<xref ref-type="bibr" rid="CR55">55</xref>]</p><p id="Par45">Neurological function will be assessed using the National Institutes of Health Stroke Scale (NIHSS) at baseline, 1&#x000a0;week after the first acupuncture treatment, and 2&#x000a0;weeks after the first acupuncture treatment. The NIHSS is widely used for assessing neurological function defect symptoms.</p></list-item><list-item><p id="Par46">Barthel Index [<xref ref-type="bibr" rid="CR56">56</xref>]</p><p id="Par47">Functional ability will be assessed using the Barthel Index at baseline, 1&#x000a0;week after the first acupuncture treatment, and 2&#x000a0;weeks after the first acupuncture treatment.</p><p id="Par48">The Barthel Index is widely used for assessing quality of life of clinical patients.</p></list-item></list>
</p></sec><sec id="Sec21"><title>Adverse events</title><p id="Par49">Adverse events (AEs) are defined as negative or unintended clinical manifestations following the treatment [<xref ref-type="bibr" rid="CR57">57</xref>]. Our investigators will collect information regarding AEs every 3&#x000a0;days. Participants will be instructed to report any abnormal reactions or uncomfortable feelings experienced to any researcher. All related and unexpected AEs will be recorded on Case Report Forms (CRFs) in detail, including time of occurrence, degree of AE, and possible causes. Patients with mild and moderate AEs will be treated for their symptoms and closely monitored as necessary by the researcher. Severe AEs will be reported to the Research Ethics Committee, which will provide medical advice to the research team within 48&#x000a0;h, and the Research Ethics Committee will determine whether the patient is eligible for further treatment associated with the study.</p></sec></sec><sec id="Sec22"><title>Data management</title><p id="Par50">All researchers including therapists, data entry clerks, the data collector, data manager, statistician, and outcome assessors will receive special training regarding the research contents and data management. During the recruitment period, our data collector will record the baseline characteristics of participants on CRFs, and all data will be assessed by the data manager. Then, as the study begins, the data collector will obtain CVR, BHI, NIHSS, and Barthel Index data at baseline and 2&#x000a0;weeks following the first treatment. Additional NIHSS and Barthel Index data will be obtained 1&#x000a0;week following the first treatment. The TCD assessment will be conducted by an appointed operator who has completed an advanced course of study in this field at Beijing Tiantan Hospital Affiliated with Capital Medical University.</p><p id="Par51">Upon conclusion of the treatment period, all participant data will be completed and recorded on the original CRFs. The data will then be entered into Excel spreadsheets by two separate data entry clerks, following which the data manager will compare the accuracy of the two datasets. If any differences are noted, corrections will be made according to, and marked on, the original CRFs. The data will be managed in accordance with the Data Protection Act of 1998 [<xref ref-type="bibr" rid="CR58">58</xref>]. All paper files related to the research will be saved in a locked filing cabinet, while electronic documents will be stored in a special computer which will remain password-protected and accessible only to the principal investigators. All research documents, including both the paper files and electronic documents, will be preserved for at least 5&#x000a0;years after publication. If readers have any questions regarding our published data, they will be permitted to contact our first author or corresponding author to ask for the original data.</p></sec><sec id="Sec23"><title>Statistical analysis</title><p id="Par52">Data analysis will be performed by statisticians who are blinded to the entire allocation and intervention process. The statisticians are affiliated with the Research Center of Clinical Epidemiology at Peking University Third Hospital in Beijing, China, which is one of the most authoritative statistics centers in the country. An intention-to-treat analysis will be conducted using the SPSS statistical software package (V.22.0) (International Business Machines Corporation). Two-tailed analyses will be conducted, with the level of statistical significance defined as <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05. Baseline characteristics, such as gender, age, NIHSS score, GCS score, previous duration, and impaired CVR, will be analyzed. The categorical data will be described as <italic>n</italic> (%), and continuous data using mean&#x02009;&#x000b1;&#x02009;SD. If the data meets the standard of the parameter test, a chi-square test will then be conducted. Independent sample <italic>t</italic> tests will be used for comparisons among the groups, while paired <italic>t</italic> tests will be used for within-group comparisons. The efficacy of the intervention will be compared between the two groups using <italic>&#x003c7;</italic>
<sup>2</sup> analysis.</p></sec><sec id="Sec24"><title>Ethical considerations</title><p id="Par53">The trial protocol is in accordance with the principles of the Declaration of Helsinki [<xref ref-type="bibr" rid="CR59">59</xref>] and was approved by the Research Ethical Committee of Beijing Hospital of Traditional Chinese Medicine at Capital Medical University on 30 November 2015 (Ethics Reference Number: 20151130). This trial was registered at ISRCTN (ID: 99117074). Each participant will be notified regarding the study protocol. Written informed consent will be obtained from every participant.</p></sec></sec><sec id="Sec25" sec-type="discussion"><title>Discussion</title><p id="Par54">This trial aims to investigate whether acupuncture utilizing the waking up the spirit needling method can improve CVR capacity in patients with acute cerebral infarction, thus reducing NIHSS scores and preventing further disease progression. Some studies [<xref ref-type="bibr" rid="CR60">60</xref>&#x02013;<xref ref-type="bibr" rid="CR62">62</xref>] have demonstrated that acupuncture may improve symptoms in patients with cerebral infarction and, according to clinical observations, acupuncture utilizing the waking up the spirit needling method may produce similar effects. Furthermore, increased focus has been directed at the relationship between CVR and cerebral infarction [<xref ref-type="bibr" rid="CR32">32</xref>]. Acupuncture is widely utilized in the treatment of cerebral infarction, though the mechanisms underlying its effects remain unclear. In this randomized, controlled study we expect that participants will experience pain relief as well as improved function and strength. Furthermore, data and evidence gained from this study will be utilized in the development of future research projects regarding the effects of acupuncture in patients with acute cerebral infarction.</p><p id="Par55">The risks of taking part in this trial are minimal. Acupuncture is a very safe treatment when conducted by properly trained clinicians. Occasionally, acupuncture can make people feel nauseous, faint, or experience a temporary increase in pain either during or after treatment.</p><p id="Par56">The global outlook for cerebral infarction is not good [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR63">63</xref>], and both first- and second-level prevention are critical at reducing the impact of this potentially life-threatening and devastating condition [<xref ref-type="bibr" rid="CR63">63</xref>&#x02013;<xref ref-type="bibr" rid="CR70">70</xref>]. CVR is an independent risk factor for the occurrence [<xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR21">21</xref>], progression [<xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>], and recurrence [<xref ref-type="bibr" rid="CR26">26</xref>] of cerebral infarction that requires attention. Some researchers have even proposed that CVR should be assessed regularly, as one of the key targets for prevention [<xref ref-type="bibr" rid="CR71">71</xref>].</p><p id="Par57">Acupuncture provides distinct advantages in that it is easy, convenient, economic, and effective. The waking up the spirit needling method and the hand and foot 12-meridian needle method are commonly used in China for the treatment of stroke patients. Both of them have shown curative effect in clinical practice. It is noted, however, that the waking up the spirit needling method using bloodletting with a three-edged needle, provides stronger stimuli to the head than the hand and foot 12-meridian needle method. Since those bloodletting acupoints are located on the head, it is reasonable to hypothesize that this method might exert an impact on cerebral blood flow. The same effect is unlikely to be obtained by the hand and foot 12-meridian needle method which takes acupoints from the extremities. Significant differences in blood flow have been observed between strong stimulation and regular acupuncture, though the mechanism underlying these differences remain unclear [<xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR41">41</xref>]. Butylphthalide [<xref ref-type="bibr" rid="CR45">45</xref>] has an effect on patients with acute cerebral infarction, the underlying mechanism maybe that it changes the CVR by changing blood flow. As with butylphthalide, we hypothesize that acupuncture utilizing the waking up the spirit needling method can improve CVR capacity in patients with acute cerebral infarction.</p><p id="Par58">We chose the hand and foot 12-meridian needle method as the control intervention. The 12 acupoints stimulated in this method are located on the arms and legs, and the stimulation provided by this technique is considered to be less than that of bloodletting utilizing a three-edged needle. Therefore, the procedure should have less effect on CVR and cerebral blood flow. The 12-acupoint method is also taught by masters of acupuncture and is quite popular in clinical treatment. Furthermore, research has indicated that it is effective in improving patients&#x02019; symptoms [<xref ref-type="bibr" rid="CR72">72</xref>]. Therefore, it is a reasonable control intervention that meets ethical standards.</p><p id="Par59">To our knowledge, the present trial marks the first attempt to investigate the efficacy of acupuncture with regard to improving CVR. The results of this trial may help to elucidate the mechanism underlying the effects of acupuncture in patients with acute stroke, which may significantly aid in the development of clinical treatment protocols and further studies regarding the underlying mechanisms of these effects. As research has indicated that adequate CVR is crucial for preventing the occurrence, progression, and recurrence of cerebral infarction, the results of this trial may also highlight the importance of regular assessment of CVR.</p><sec id="Sec26"><title>Trial status</title><p id="Par60">At the time of manuscript submission, we started to seek out potentially appropriate patients from the three acupuncture wards of Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University according to the inclusion and exclusion criteria and provided them with detailed information about the study. About six patient agreed to participate, after which followed written informed consent and baseline assessments and randomization. We also tried to do some test work before the real recruitment started. However, by the time of manuscript submission we had not started to apply the interventions.</p></sec></sec></body><back><app-group><app id="App1"><sec id="Sec27"><title>Additional file</title><p id="Par68">
<media position="anchor" xlink:href="13063_2017_2013_MOESM1_ESM.pdf" id="MOESM1"><label>Additional file 1:</label><caption><p>SPIRIT Checklist. The SPIRIT Checklist document. (PDF 217&#x000a0;kb)</p></caption></media>
</p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>AE</term><def><p id="Par5">Adverse event</p></def></def-item><def-item><term>AHA</term><def><p id="Par6">American Heart Association</p></def></def-item><def-item><term>ASA</term><def><p id="Par7">American Stroke Association</p></def></def-item><def-item><term>BHI</term><def><p id="Par8">Breath-holding Index</p></def></def-item><def-item><term>CRF</term><def><p id="Par9">Case Report Form</p></def></def-item><def-item><term>CT</term><def><p id="Par10">Computed tomography</p></def></def-item><def-item><term>CVR</term><def><p id="Par11">Cerebrovascular reserve</p></def></def-item><def-item><term>GCS</term><def><p id="Par12">Glasgow Coma Scale</p></def></def-item><def-item><term>M1</term><def><p id="Par13">Middle cerebral artery</p></def></def-item><def-item><term>MFV</term><def><p id="Par14">Mean blood flow velocity</p></def></def-item><def-item><term>MR</term><def><p id="Par15">Magnetic resonance</p></def></def-item><def-item><term>NIHSS</term><def><p id="Par16">National Institutes of Health Stroke Scale</p></def></def-item><def-item><term>PET</term><def><p id="Par17">Positron emission tomography</p></def></def-item><def-item><term>TCD</term><def><p id="Par18">Transcranial Doppler</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (doi:10.1186/s13063-017-2013-5) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would like to express their sincere appreciation to Jingqing Sun, Guiling Wang, and Yingxue Cui for their helpful advice regarding the research design, and to Xin Du and Tao Zhang for the statistical analysis.</p><sec id="FPar1"><title>Funding</title><p id="Par61">This study was supported by Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (Grant No. ZYLX201412), Beijing Traditional Chinese Medicine Science and Technology Project (Grant No. JJ2014-10), and Beijing Natural Science Foundation (Grant No.7154206).</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par62">Not applicable.</p></sec><sec id="FPar3"><title>Authors&#x02019; contributions</title><p id="Par63">S-SW, T-TM, and L-PW conceived and designed this study. S-SW and T-TM drafted and wrote the first manuscript describing the protocol. L-PW, LL, and H-LL revised the protocol. LL, H-LL, BL, and Y-BF participated in the design of the trial and will conduct the acupuncture sessions. All authors read and approved the final manuscript.</p></sec><sec id="FPar4"><title>Competing interests</title><p id="Par64">The authors declare that they have no competing interests.</p></sec><sec id="FPar5"><title>Consent for publication</title><p id="Par65">Not applicable.</p></sec><sec id="FPar6"><title>Ethics approval and consent to participate</title><p id="Par66">Ethical approval was granted on 3 February 2016, by the Research Ethical Committee of Beijing Hospital of Traditional Chinese Medicine Affiliated with Capital Medical University (ref: 20151130). Written informed consent will be obtained from all participants. Study results will be published in peer-reviewed journals.</p></sec><sec id="FPar7"><title>Publisher&#x02019;s Note</title><p id="Par67">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bielewicz</surname><given-names>J</given-names></name><name><surname>Kurzepa</surname><given-names>J</given-names></name><name><surname>Lagowska-Lenard</surname><given-names>M</given-names></name><etal/></person-group><article-title>The novel views on the pathomechanism of ischemic stroke</article-title><source>Wiad Lek</source><year>2010</year><volume>63</volume><issue>3</issue><fpage>213</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">21125745</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>To prevent and treat stroke completely and systematically and reduce its damages</article-title><source>Shanghai Med J.</source><year>2010</year><volume>09</volume><fpage>793</fpage><lpage>4</lpage></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name></person-group><article-title>The clinical curative effect observation of treating acute cerebral infarction in the very early stage with acupuncture</article-title><source>J Clin Acupunct Moxibustion.</source><year>2015</year><volume>03</volume><fpage>31</fpage><lpage>2</lpage></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>CJ</given-names></name><name><surname>Lopez</surname><given-names>AD</given-names></name></person-group><article-title>Measuring the global burden of disease</article-title><source>N Engl J Med</source><year>2013</year><volume>369</volume><issue>5</issue><fpage>448</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1201534</pub-id><pub-id pub-id-type="pmid">23902484</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><etal/></person-group><article-title>To observe the heavy burden of stroke in China from the view of the world</article-title><source>J Public Health Prev Med.</source><year>2016</year><volume>01</volume><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzhi</surname><given-names>W</given-names></name></person-group><article-title>The epidemiologic feature of stroke in China and community interventions</article-title><source>Chinese J Frontiers Med Sci (Electronic Version)</source><year>2009</year><volume>02</volume><fpage>49</fpage><lpage>53</lpage></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name></person-group><article-title>Analysis about the effects of treating stroke with hyperbaric oxygen and the related sequela</article-title><source>Chin J Pract Intern Med.</source><year>2007</year><volume>S1</volume><fpage>256</fpage><lpage>7</lpage></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><article-title>Analysis about prevention measures for stroke</article-title><source>Chin J Pract Nerv Dis.</source><year>2011</year><volume>01</volume><fpage>52</fpage><lpage>3</lpage></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>L</given-names></name></person-group><article-title>The recent situation of researches about the young stroke</article-title><source>China Med Abstr.</source><year>2005</year><volume>02</volume><fpage>237</fpage><lpage>9</lpage></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuedong</surname><given-names>T</given-names></name><name><surname>Qiang</surname><given-names>D</given-names></name></person-group><article-title>The research progress about reasons and danger factors of the young stroke</article-title><source>Chin J Cerebrovasc Dis (Electronic Edition)</source><year>2010</year><volume>03</volume><fpage>182</fpage><lpage>90</lpage></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Rapid health transition in China, 1990&#x02013;2010: findings from the Global Burden of Disease Study 2010</article-title><source>Lancet</source><year>2013</year><volume>381</volume><issue>9882</issue><fpage>1987</fpage><lpage>2015</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(13)61097-1</pub-id><pub-id pub-id-type="pmid">23746901</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Ministry of Health of the PRC, The main conditions of the third time national death inquiry. China Cancer. 2008;05:344&#x02013;5. <ext-link ext-link-type="uri" xlink:href="http://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&#x00026;dbname=CJFD2008&#x00026;filename=ZHLU200805002&#x00026;uid=WEEvREcwSlJHSldTTEYzVTE0bUVvOXd1d1dOREZodjNXRzhGVDAwNlBCTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4ggI8Fm4gTkoUKaID8j8gFw!!&#x00026;v=MDUwNjdTN0RoMVQzcVRyV00xRnJDVVJMMmZZZWRzRnl2bVVyckFQeVhIZTdHNEh0bk1xbzlGWm9SOGVYMUx1eFk=">http://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&#x00026;dbname=CJFD2008&#x00026;filename=ZHLU200805002&#x00026;uid=WEEvREcwSlJHSldTTEYzVTE0bUVvOXd1d1dOREZodjNXRzhGVDAwNlBCTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4ggI8Fm4gTkoUKaID8j8gFw!!&#x00026;v=MDUwNjdTN0RoMVQzcVRyV00xRnJDVVJMMmZZZWRzRnl2bVVyckFQeVhIZTdHNEh0bk1xbzlGWm9SOGVYMUx1eFk=</ext-link>.</mixed-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><etal/></person-group><article-title>The influence of ideal cardiovascular healthy behaviors and factors for new ischemic stroke</article-title><source>Chinese J Hypertens.</source><year>2012</year><volume>04</volume><fpage>342</fpage><lpage>6</lpage></element-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">CDC in China, <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/globalhealth/countries/china/pdf/china.pdf">http://www.cdc.gov/globalhealth/countries/china/pdf/china.pdf</ext-link>.</mixed-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>X</given-names></name></person-group><article-title>The relationship between cerebral vascular reserve and ischemic stroke</article-title><source>Chinese J Stroke.</source><year>2007</year><volume>08</volume><fpage>652</fpage><lpage>4</lpage></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Guojin</surname><given-names>Z</given-names></name><name><surname>Zengrong</surname><given-names>Z</given-names></name></person-group><source>Research progress about cerebrovascular disease abroad</source><year>2000</year><publisher-loc>Beijing</publisher-loc><publisher-name>the medicine science and technology press of China</publisher-name></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Changlu</surname><given-names>H</given-names></name><name><surname>Wenming</surname><given-names>W</given-names></name><name><surname>Yingrui</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Research about cerebral vascular reserve and progressive cerebral infarction</article-title><source>Contemporary Med.</source><year>2011</year><volume>05</volume><fpage>13</fpage><lpage>4</lpage></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derdeyn</surname><given-names>CP</given-names></name><name><surname>Videen</surname><given-names>TO</given-names></name><name><surname>Yundt</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited</article-title><source>Brain</source><year>2002</year><volume>125</volume><issue>Pt 3</issue><fpage>595</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1093/brain/awf047</pub-id><pub-id pub-id-type="pmid">11872616</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gur</surname><given-names>AY</given-names></name><name><surname>Bova</surname><given-names>I</given-names></name><name><surname>Bornstein</surname><given-names>NM</given-names></name></person-group><article-title>Is impaired cerebral vasomotor reactivity a predictive factor of stroke in asymptomatic patients</article-title><source>Stroke</source><year>1996</year><volume>27</volume><issue>12</issue><fpage>2188</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1161/01.STR.27.12.2188</pub-id><pub-id pub-id-type="pmid">8969778</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markus</surname><given-names>H</given-names></name><name><surname>Cullinane</surname><given-names>M</given-names></name></person-group><article-title>Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion</article-title><source>Brain</source><year>2001</year><volume>124</volume><issue>Pt 3</issue><fpage>457</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1093/brain/124.3.457</pub-id><pub-id pub-id-type="pmid">11222446</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogasawara</surname><given-names>K</given-names></name><name><surname>Ogawa</surname><given-names>A</given-names></name><name><surname>Terasaki</surname><given-names>K</given-names></name><etal/></person-group><article-title>Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography</article-title><source>J Cereb Blood Flow Metab</source><year>2002</year><volume>22</volume><issue>9</issue><fpage>1142</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1097/00004647-200209000-00012</pub-id><pub-id pub-id-type="pmid">12218420</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>FJ</given-names></name><name><surname>Segura</surname><given-names>T</given-names></name><name><surname>Castellanos</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cerebral hemodynamic reserve and early neurologic deterioration in acute ischemic stroke</article-title><source>J Cereb Blood Flow Metab</source><year>2004</year><volume>24</volume><issue>11</issue><fpage>1267</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">15545922</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>So</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery</article-title><source>Stroke</source><year>2005</year><volume>36</volume><issue>7</issue><fpage>1485</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000170709.95185.b1</pub-id><pub-id pub-id-type="pmid">15947261</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshorov</surname><given-names>AV</given-names></name><name><surname>Kozlova</surname><given-names>EA</given-names></name><name><surname>Moldotashova</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Differential approach to the application of hyperventilation in acute period of severe brain injury in relation to cerebral circulation</article-title><source>Zh Vopr Neirokhir Im N N Burdenko</source><year>2004</year><volume>2</volume><fpage>26</fpage><lpage>31</lpage></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>X</given-names></name></person-group><article-title>Research of urokallikrein improving cerebral vascular reserve capacity</article-title><source>Chin J Stroke.</source><year>2007</year><volume>06</volume><fpage>545</fpage><lpage>8</lpage></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widder</surname><given-names>B</given-names></name><name><surname>Kleiser</surname><given-names>B</given-names></name><name><surname>Krapf</surname><given-names>H</given-names></name></person-group><article-title>Course of cerebrovascular reactivity in patients with carotid artery occlusions</article-title><source>Stroke</source><year>1994</year><volume>25</volume><issue>10</issue><fpage>1963</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1161/01.STR.25.10.1963</pub-id><pub-id pub-id-type="pmid">7916501</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bundo</surname><given-names>M</given-names></name><name><surname>Inao</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>A</given-names></name><etal/></person-group><article-title>Changes of neural activity correlate with the severity of cortical ischemia in patients with unilateral major cerebral artery occlusion</article-title><source>Stroke</source><year>2002</year><volume>33</volume><issue>1</issue><fpage>61</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1161/hs0102.101816</pub-id><pub-id pub-id-type="pmid">11779890</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>S</given-names></name><name><surname>Houkin</surname><given-names>K</given-names></name><name><surname>Kamiyama</surname><given-names>H</given-names></name><etal/></person-group><article-title>Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it?</article-title><source>Stroke</source><year>2001</year><volume>32</volume><issue>9</issue><fpage>2110</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1161/hs0901.095692</pub-id><pub-id pub-id-type="pmid">11546904</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaer</surname><given-names>RA</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cerebral reserve is decreased in elderly patients with carotid stenosis</article-title><source>J Vasc Surg</source><year>2010</year><volume>52</volume><issue>3</issue><fpage>569</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2010.04.021</pub-id><pub-id pub-id-type="pmid">20620003</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vagal</surname><given-names>AS</given-names></name><name><surname>Leach</surname><given-names>JL</given-names></name><name><surname>Fernandez-Ulloa</surname><given-names>M</given-names></name><etal/></person-group><article-title>The acetazolamide challenge: techniques and applications in the evaluation of chronic cerebral ischemia</article-title><source>AJNR Am J Neuroradiol</source><year>2009</year><volume>30</volume><issue>5</issue><fpage>876</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.3174/ajnr.A1538</pub-id><pub-id pub-id-type="pmid">19246526</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Chazen</surname><given-names>JL</given-names></name><name><surname>Hartman</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis</article-title><source>Stroke</source><year>2012</year><volume>43</volume><issue>11</issue><fpage>2884</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.112.663716</pub-id><pub-id pub-id-type="pmid">23091119</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Yun</surname><given-names>X</given-names></name></person-group><article-title>Different stages of cerebral vascular reserve and the application value for ischemic stroke</article-title><source>Chinese J Stroke.</source><year>2007</year><volume>08</volume><fpage>675</fpage><lpage>8</lpage></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Comparative efficacy of acupuncture with <italic>Tongnaohuouo</italic> and regular treatment</article-title><source>J Clin Neurology.</source><year>2010</year><volume>06</volume><fpage>469</fpage><lpage>71</lpage></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>D</given-names></name></person-group><article-title>Efficacy observation about treating acute cerebral infarction using <italic>Xingnaokaiqiao</italic> as an adjunctive therapy</article-title><source>J Emerg Tradit Chin Med.</source><year>2005</year><volume>05</volume><fpage>398</fpage><lpage>9</lpage></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Shen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Clinical curative effect of <italic>xingnaokaiqiao</italic> needling method acupuncture plus scalp acupuncture on acute cerebral infarction and the influence on hs-CRP</article-title><source>Chin J Rehabil Theory Pract.</source><year>2008</year><volume>11</volume><fpage>1059</fpage><lpage>61</lpage></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Influence of acupuncture on plasma endothelin in patients with acute cerebral infarction</article-title><source>Acupuncture Res.</source><year>2000</year><volume>03</volume><fpage>214</fpage><lpage>6</lpage></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Junying</surname><given-names>Z</given-names></name><name><surname>Xiangsheng</surname><given-names>C</given-names></name></person-group><source>Experience set of acupuncture Master Wang Leting</source><year>2004</year><publisher-loc>Beijing</publisher-loc><publisher-name>People&#x02019;s Medical Publishing House</publisher-name></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Meng</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Influence of needling PC6 with different frequency on blood flow of MCAo model rats</article-title><source>J Sichuan Tradit Chin Med.</source><year>2012</year><volume>07</volume><fpage>43</fpage><lpage>5</lpage></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>A</given-names></name></person-group><article-title>Influence of electroacupuncture on expression of EPO and blood flow in MCAO model rats</article-title><source>Chin J Rehabil.</source><year>2013</year><volume>05</volume><fpage>323</fpage><lpage>6</lpage></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Influence of needling different acupoints on blood flow in cerebral ischemia model rats</article-title><source>Chin Acupunct Moxibustion.</source><year>2009</year><volume>03</volume><fpage>213</fpage><lpage>6</lpage></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Shenglin</surname><given-names>S</given-names></name></person-group><article-title>Influence of eye acupuncture on blood flow and blood flow in velocity cerebral ischemia reperfusion rats</article-title><source>Chin J Public Health.</source><year>2013</year><volume>08</volume><fpage>1181</fpage><lpage>3</lpage></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>The effect comparison of treating acute cerebral infarction Acupuncture with Tongnaohuoluo and regular treatment</article-title><source>J Clin Neurol.</source><year>2010</year><volume>06</volume><fpage>469</fpage><lpage>71</lpage></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin-kai</surname><given-names>Z</given-names></name><name><surname>Ying-xing</surname><given-names>J</given-names></name></person-group><article-title>Observation on therapeutic effect of acupuncture and medication for 30 cases of post-stroke depression</article-title><source>J Acupuncture Tuina Sci</source><year>2007</year><volume>5</volume><issue>4</issue><fpage>230</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1007/s11726-007-0236-9</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JD</given-names></name><name><surname>Chon</surname><given-names>JS</given-names></name><name><surname>Jeong</surname><given-names>HK</given-names></name><etal/></person-group><article-title>The cerebrovascular response to traditional acupuncture after stroke</article-title><source>Neuroradiology</source><year>2003</year><volume>45</volume><issue>11</issue><fpage>780</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1007/s00234-003-1080-3</pub-id><pub-id pub-id-type="pmid">12942221</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name></person-group><article-title>The influence of butylphthalide on nerve function and cerebrovascular reserve function of patients with acute cerebral infarction</article-title><source>Chin J Pract Nerv Dis.</source><year>2016</year><volume>03</volume><fpage>109</fpage><lpage>10</lpage></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>The clinical application value of using TCD to measure cerebral vascular reserve</article-title><source>Med Recapitulate.</source><year>2009</year><volume>18</volume><fpage>2819</fpage><lpage>21</lpage></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aaslid</surname><given-names>R</given-names></name><name><surname>Markwalder</surname><given-names>TM</given-names></name><name><surname>Nornes</surname><given-names>H</given-names></name></person-group><article-title>Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries</article-title><source>J Neurosurg</source><year>1982</year><volume>57</volume><issue>6</issue><fpage>769</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.3171/jns.1982.57.6.0769</pub-id><pub-id pub-id-type="pmid">7143059</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bishop</surname><given-names>CC</given-names></name><name><surname>Powell</surname><given-names>S</given-names></name><name><surname>Rutt</surname><given-names>D</given-names></name><etal/></person-group><article-title>Transcranial Doppler measurement of middle cerebral artery blood flow velocity: a validation study</article-title><source>Stroke</source><year>1986</year><volume>17</volume><issue>5</issue><fpage>913</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1161/01.STR.17.5.913</pub-id><pub-id pub-id-type="pmid">3764963</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panczel</surname><given-names>G</given-names></name><name><surname>Bonoczk</surname><given-names>P</given-names></name><name><surname>Nagy</surname><given-names>Z</given-names></name></person-group><article-title>Impairment of vasoreactivity in brainstem and hemispheral small vessel disease: comparative study</article-title><source>Ideggyogy Sz</source><year>2002</year><volume>55</volume><issue>3-4</issue><fpage>95</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">12122986</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratanakorn</surname><given-names>D</given-names></name><name><surname>Greenberg</surname><given-names>JP</given-names></name><name><surname>Meads</surname><given-names>DB</given-names></name><etal/></person-group><article-title>Middle cerebral artery flow velocity correlates with common carotid artery volume flow rate after CO2 inhalation</article-title><source>J Neuroimaging</source><year>2001</year><volume>11</volume><issue>4</issue><fpage>401</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1111/j.1552-6569.2001.tb00069.x</pub-id><pub-id pub-id-type="pmid">11677880</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Voges</surname><given-names>M</given-names></name><name><surname>Piepgras</surname><given-names>U</given-names></name><etal/></person-group><article-title>Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. A comparison with acetazolamide as vasodilatory stimulus</article-title><source>Stroke</source><year>1995</year><volume>26</volume><issue>1</issue><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1161/01.STR.26.1.96</pub-id><pub-id pub-id-type="pmid">7839406</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jauch</surname><given-names>EC</given-names></name><name><surname>Saver</surname><given-names>JL</given-names></name><name><surname>Adams</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association</article-title><source>Stroke</source><year>2013</year><volume>44</volume><issue>3</issue><fpage>870</fpage><lpage>947</lpage><pub-id pub-id-type="doi">10.1161/STR.0b013e318284056a</pub-id><pub-id pub-id-type="pmid">23370205</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">State Administration of Traditional Chinese Medicine. The diagnosis and curative effect evaluation standard of stroke in Traditional Chinese Medicine. 1996.</mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="other">National Collaborating Centre for Chronic Conditions (UK) (UK NCCF). Stroke: national clinical guideline for diagnosis and initial management of acute stroke and transient ischaemic attack (TIA). London: Royal College of Physicians (UK); 2008. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/21698846">https://www.ncbi.nlm.nih.gov/pubmed/21698846</ext-link>.</mixed-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>EJ</given-names></name><name><surname>Heinemann</surname><given-names>AW</given-names></name><name><surname>Lovell</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Impairment and disability: their relation during stroke rehabilitation</article-title><source>Arch Phys Med Rehabil</source><year>1998</year><volume>79</volume><issue>3</issue><fpage>329</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/S0003-9993(98)90015-6</pub-id><pub-id pub-id-type="pmid">9523787</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Tan</surname><given-names>S</given-names></name></person-group><article-title>The applicability and related researches about using Barthel and Rankin in stroke register</article-title><source>Chin J Evid Based Med.</source><year>2004</year><volume>12</volume><fpage>871</fpage><lpage>4</lpage></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>G</given-names></name><etal/></person-group><article-title>Efficacy and safety of ginger-salt-indirect moxibustion for urge urinary incontinence after stroke: protocol for a pilot multicentre randomised controlled trial</article-title><source>BMJ Open</source><year>2014</year><volume>4</volume><issue>10</issue><fpage>e6326</fpage></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>P</given-names></name></person-group><article-title>Health research and the Data Protection Act 1998</article-title><source>J Health Serv Res Policy.</source><year>2003</year><volume>8</volume><issue>Suppl 1</issue><fpage>S1</fpage><lpage>S24</lpage><pub-id pub-id-type="pmid">12869334</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="other">World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191&#x02013;4. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/24141714">https://www.ncbi.nlm.nih.gov/pubmed/24141714</ext-link>.</mixed-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>A systematic review for treating acute cerebral infarction with acupuncture</article-title><source>China J Tradit Chin Med Pharm.</source><year>2009</year><volume>01</volume><fpage>101</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/S0254-6272(09)60042-X</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The influence on motor function of acute cerebral infarction patients with early rehabilitation and acupuncture treatment</article-title><source>Chinese J Phys Med Rehabil.</source><year>2001</year><volume>04</volume><fpage>33</fpage><lpage>5</lpage></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><etal/></person-group><article-title>A randomized controlled pilot study about treating acute cerebral infarction with acupuncture</article-title><source>Chinese J Neurology.</source><year>2003</year><volume>04</volume><fpage>11</fpage><lpage>5</lpage></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feigin</surname><given-names>VL</given-names></name><name><surname>Mensah</surname><given-names>GA</given-names></name><name><surname>Norrving</surname><given-names>B</given-names></name><etal/></person-group><article-title>Atlas of the global burden of stroke (1990&#x02013;2013): the GBD 2013 Study</article-title><source>Neuroepidemiology</source><year>2015</year><volume>45</volume><issue>3</issue><fpage>230</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1159/000441106</pub-id><pub-id pub-id-type="pmid">26505985</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacco</surname><given-names>RL</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Broderick</surname><given-names>JP</given-names></name><etal/></person-group><article-title>American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke. Risk factors</article-title><source>Stroke</source><year>1997</year><volume>28</volume><issue>7</issue><fpage>1507</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1161/01.STR.28.7.1507</pub-id><pub-id pub-id-type="pmid">9227708</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Mozaffarian</surname><given-names>D</given-names></name><name><surname>Roger</surname><given-names>VL</given-names></name><etal/></person-group><article-title>Heart disease and stroke statistics&#x02014;2014 update: a report from the American Heart Association</article-title><source>Circulation</source><year>2014</year><volume>129</volume><issue>3</issue><fpage>e28</fpage><lpage>e292</lpage><pub-id pub-id-type="doi">10.1161/01.cir.0000441139.02102.80</pub-id><pub-id pub-id-type="pmid">24352519</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samsa</surname><given-names>GP</given-names></name><name><surname>Bian</surname><given-names>J</given-names></name><name><surname>Lipscomb</surname><given-names>J</given-names></name><etal/></person-group><article-title>Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost</article-title><source>Stroke</source><year>1999</year><volume>30</volume><issue>2</issue><fpage>338</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1161/01.STR.30.2.338</pub-id><pub-id pub-id-type="pmid">9933269</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petty</surname><given-names>GW</given-names></name><name><surname>Brown</surname><given-names>RJ</given-names></name><name><surname>Whisnant</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence</article-title><source>Stroke</source><year>2000</year><volume>31</volume><issue>5</issue><fpage>1062</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1161/01.STR.31.5.1062</pub-id><pub-id pub-id-type="pmid">10797166</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellekjaer</surname><given-names>H</given-names></name><name><surname>Holmen</surname><given-names>J</given-names></name><name><surname>Indredavik</surname><given-names>B</given-names></name><etal/></person-group><article-title>Epidemiology of stroke in Innherred, Norway, 1994 to 1996. Incidence and 30-day case-fatality rate</article-title><source>Stroke</source><year>1997</year><volume>28</volume><issue>11</issue><fpage>2180</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1161/01.STR.28.11.2180</pub-id><pub-id pub-id-type="pmid">9368561</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthi</surname><given-names>RV</given-names></name><name><surname>Moran</surname><given-names>AE</given-names></name><name><surname>Feigin</surname><given-names>VL</given-names></name><etal/></person-group><article-title>Stroke prevalence, mortality and disability-adjusted life years in adults aged 20&#x02013;64 Years in 1990&#x02013;2013: data from the Global Burden of Disease 2013 Study</article-title><source>Neuroepidemiology</source><year>2015</year><volume>45</volume><issue>3</issue><fpage>190</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1159/000441098</pub-id><pub-id pub-id-type="pmid">26505983</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthi</surname><given-names>RV</given-names></name><name><surname>DeVeber</surname><given-names>G</given-names></name><name><surname>Feigin</surname><given-names>VL</given-names></name><etal/></person-group><article-title>Stroke prevalence, mortality and disability-adjusted life years in children and youth aged 0&#x02013;19 years: data from the Global and Regional Burden of Stroke 2013</article-title><source>Neuroepidemiology</source><year>2015</year><volume>45</volume><issue>3</issue><fpage>177</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1159/000441087</pub-id><pub-id pub-id-type="pmid">26505982</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klijn</surname><given-names>CJ</given-names></name><name><surname>Kappelle</surname><given-names>LJ</given-names></name><name><surname>Tulleken</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors</article-title><source>Stroke</source><year>1997</year><volume>28</volume><issue>10</issue><fpage>2084</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1161/01.STR.28.10.2084</pub-id><pub-id pub-id-type="pmid">9341723</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><article-title>The observation of treating 150 patients with cerebral infarction with hand and foot twelve-meridian acupuncture</article-title><source>China Mod Med.</source><year>2009</year><volume>17</volume><fpage>82</fpage><lpage>3</lpage></element-citation></ref></ref-list></back></article>